Critical care in obstetrics: pregnancy-specific conditions

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 22, Issue 5, 2008, Pages 825-846

  Williams, Jennifer ^a   Mozurkewich, Ellen ^a   Chilimigras, Julie ^a   Van De Ven, Cosmas ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

acute fatty liver; amniotic fluid embolism; obstetric haemorrhage; peripartum cardiomyopathy; pre eclampsia HELLP syndrome; trauma

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; FRESH FROZEN PLASMA; HEPARIN; HYDRALAZINE; HYPERTENSIVE FACTOR; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM SULFATE; METHYLERGOMETRINE MALEATE; MISOPROSTOL; OXYTOCIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; STEROID; WARFARIN;

ACCIDENT PREVENTION; AMNION FLUID EMBOLISM; ARTERY LIGATION; ARTIFICIAL EMBOLISM; CARDIOMYOPATHY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CRYOPRECIPITATE; CRYSTALLOID; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG MEGADOSE; ECLAMPSIA; FALLING; FATTY LIVER; FEMALE; FETUS MONITORING; FLUID RESUSCITATION; HEART FAILURE; HELLP SYNDROME; HUMAN; HYSTERECTOMY; INTENSIVE CARE; INTRACARDIAC THROMBOSIS; LIVER TRANSPLANTATION; LOADING DRUG DOSE; MATERNAL CARE; MATERNAL MORTALITY; MEDICAL ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTETRIC CARE; OBSTETRIC HEMORRHAGE; PARTNER VIOLENCE; PATHOPHYSIOLOGY; PENETRATING TRAUMA; PLACENTA PREVIA; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEIZURE; SOLUTIO PLACENTAE; THROMBOCYTE TRANSFUSION; TRAFFIC ACCIDENT; UTERINE ATONY;

CRITICAL CARE; DISSEMINATED INTRAVASCULAR COAGULATION; FATTY LIVER; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PRENATAL CARE; PROGNOSIS; WOUNDS AND INJURIES;

EID: 50849104778     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2008.06.003     Document Type: Review

References (96)

1. Jeani Chang M.P.H., Laurie D., Elam-Evans P.D., et al. Pregnancy-related mortality surveillance - United States, 1991-1999. MMWR Morbid Mortal Weekly Rep 52 SS02 (2003) 1-8
2. Khan K.S., Wojdyla D., Say L., et al. WHO analysis of causes of maternal death: a systematic review. Lancet 367 (2006) 1066-1074
3. Tsu V.D., Langer A., and Aldrich T. Postpartum hemorrhage in developing countries: is the public health community using the right tools?. Int J Gynaecol Obstet 85 Suppl 1 (2004) S42-S51
4. Doumouchtsis S.K., Papageorghiou A.T., and Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv 62 (2007) 540-547
5. Chichakli L.O., Atrash H.K., Mackay A.P., et al. Pregnancy-related mortality in the United States due to hemorrhage: 1979-1992. Obstet Gynecol 94 (1999) 721-725
6. Cohen W.R. Hemorrhagic shock in obstetrics. J Perinat Med 34 (2006) 263-271
7. Chong Y.-S., Su L.-L., and Arulkumaran S. Current strategies for the prevention of postpartum haemorrhage in the third stage of labour. Curr Opin Obstet Gynecol 16 (2004) 143-150
8. Letsky E.A. Disseminated intravascular coagulation. Best Pract Res Clin Obstet Gynaecol 15 (2001) 623-644
9. Bick R.L. Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: guidelines for care. Clin Appl Thromb Hemost 8 (2002) 1-31
10. Djelmis J., Ivanisevic M., Kurjak A., et al. Hemostatic problems before, during and after delivery. J Perinat Med 29 (2001) 241-246
11. Kobayashi T., Terao T., Maki M., et al. Diagnosis and management of acute obstetrical DIC. Semin Thrombosis Hemostasis 27 (2001) 161-167
12. DeLoughery T.G. Critical care clotting catastrophies. Crit Care Clin 21 (2005) 531-562
13. Pepas L.P., Arif-Adib M., and Kadir R.A. Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. Obstet Gynecol 108 (2006) 757-761
14. Burtelow M., Riley E., Druzin M., et al. How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion 47 (2007) 1564-1572
15. Lim Y., Loo C.C., Chia V., et al. Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. Int J Gynaecol Obstet 87 (2004) 178-179
16. Mousa H.A., and Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 1 (2007) CD003249
17. ACOG Practice Bulletin. Diagnosis and Management of Preeclampsia and Eclampsia. Clinical Management Guidelines for Obstetrician-Gynecologists (2002), American College of Obstetricians and Gynecologists, Washington D.C. Number 33
18. Villar J., Say L., Gulmezoglu M., et al. Eclampsia and pre-eclampsia: a world health problem for 2000 years. In: Critchley H., Maclean A., Poston L., and Walker J. (Eds). Pre-eclampsia (2003), Royal College of Obstetricians and Gynaecologists, London 210-225
19. Hanna J., Goldman-Wohl D., Hamani Y., et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 12 (2006) 1065-1074
20. Lyall F. Mechanisms regulating cytotrophoblast invasion in normal pregnancy and pre-eclampsia. Aust N Z J Obstet Gynaecol 46 (2006) 266-273
21. Brosens J.J., Pijnenborg R., and Brosens I.A. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol 187 (2002) 1416-1423
22. Karumanchi S.A., and Epstein F.H. Placental ischemia and soluble fms-like tyrosine kinase 1: cause or consequence of preeclampsia?. Kidney Int 71 (2007) 959-961
23. Lopez-Novoa J.M. Soluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsia. Nephrol Dial Transplant 22 (2007) 712-714
24. Levine R.J., Maynard S.E., Qian C., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004) 672-683
25. Widmer M., Villar J., Benigni A., et al. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet Gynecol 109 (2007) 168-180
26. Baumwell S., and Karumanchi S.A. Pre-eclampsia: clinical manifestations and molecular mechanisms. Nephron 106 (2007) c72-c81
27. Poston L. Endothelial dysfunction in pre-eclampsia. Pharmacol Rep 58 Suppl (2006) 69-74
28. von Dadelszen P., Menzies J., Gilgoff S., et al. Evidence-based management for preeclampsia. Front Biosci 12 (2007) 2876-2889
29. Sibai B.M. Magnesium sulfate prophylaxis in preeclampsia: evidence from randomized trials. Clin Obstet Gynecol 48 (2005) 478-488
30. Sibai B.M., Mercer B.M., Schiff E., et al. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 171 (1994) 818-822
31. Sibai B.M. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 105 (2005) 402-410
32. Sibai B.M. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 103 (2004) 981-991
33. Martin Jr. J.N., Rose C.H., and Briery C.M. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 195 (2006) 914-934
34. Fonseca J.E., Méndez F., Cataño C., et al. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 193 (2005) 1591-1598
35. Nassar A.H., Adra A.M., Chakhtoura N., et al. Severe preeclampsia remote from term: labor induction or elective cesarean delivery?. Am J Obstet Gynecol 179 (1998) 1210-1213
36. Park K.H., Cho Y.K., Lee C.M., et al. Effect of preeclampsia, magnesium sulfate prophylaxis, and maternal weight on labor induction: a retrospective analysis. Gynecol Obstet Invest 61 (2006) 40-44
37. Xenakis E.M., Piper J.M., Field N., et al. Preeclampsia: is induction of labor more successful?. Obstet Gynecol 89 (1997) 600-603
38. Castro M.A., Fassett M.J., Reynolds T.B., et al. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol 181 (1999) 389-395
39. Mjahed K., Charra B., Hamoudi D., et al. Acute fatty liver of pregnancy. Arch Gynecol Obstet 274 (2006) 349-353
40. Pockros P.J., Peters R.L., and Reynolds T.B. Idiopathic fatty liver of pregnancy: findings in ten cases. Medicine (Baltimore) 63 (1984) 1-11
41. Fesenmeier M.F., Coppage K.H., Lambers D.S., et al. Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol 192 (2005) 1416-1419
42. Schoeman M.N., Batey R.G., and Wilcken B. Recurrent acute fatty liver of pregnancy associated with a fatty-acid oxidation defect in the offspring. Gastroenterology 100 (1991) 544-548
43. Ibdah J.A., Bennett M.J., Rinaldo P., et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 340 (1999) 1723-1731
44. Castro M.A., Goodwin T.M., Shaw K.J., et al. Disseminated intravascular coagulation and antithrombin III depression in acute fatty liver of pregnancy. Am J Obstet Gynecol 174 (1996) 211-216
45. Ibdah J.A. Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications. World J Gastroenterol 12 (2006) 7397-7404
46. Pearson G.D., Veille J.C., Rahimtoola S., et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 283 (2000) 1183-1188
47. Elkayam U., Akhter M.W., Singh H., et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 111 (2005) 2050-2055
48. Brar S.S., Khan S.S., Sandhu G.K., et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol 100 (2007) 302-304
49. Fett J.D., Carraway R.D., Dowell D.L., et al. Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti. Am J Obstet Gynecol 186 (2002) 1005-1010
50. Sliwa K., Skudicky D., Bergemann A., et al. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol 35 (2000) 701-705
51. O'Connell J.B., Costanzo-Nordin M.R., Subramanian R., et al. Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics. J Am Coll Cardiol 8 (1986) 52-56
52. Bultmann B.D., Klingel K., Nabauer M., et al. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 193 (2005) 363-365
53. Cenac A., Beaufils H., Soumana I., et al. Absence of humoral autoimmunity in peripartum cardiomyopathy. A comparative study in Niger. Int J Cardiol 26 (1990) 49-52
54. Demakis J.G., and Rahimtoola S.H. Peripartum cardiomyopathy. Circulation 44 (1971) 964-968
55. Demakis J.G., Rahimtoola S.H., Sutton G.C., et al. Natural course of peripartum cardiomyopathy. Circulation 44 (1971) 1053-1061
56. Hu C.L., Li Y.B., Zou Y.G., et al. Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart 93 (2007) 488-490
57. Egan D.J., Bisanzo M.C., and Hutson H.R. Emergency department evaluation and management of peripartum cardiomyopathy. J Emerg Med (2007)
58. Fuster V., Stein B., Halperin J.L., et al. Antithrombotic therapy in cardiac disease: an approach based on pathogenesis and risk stratification. Am J Cardiol 65 (1990) 38C-44C
59. Amos A.M., Jaber W.A., and Russell S.D. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J 152 (2006) 509-513
60. Chapa J.B., Heiberger H.B., Weinert L., et al. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 105 (2005) 1303-1308
61. Elkayam U., Tummala P.P., Rao K., et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 344 (2001) 1567-1571
62. Sliwa K., Forster O., Zhanje F., et al. Outcome of subsequent pregnancy in patients with documented peripartum cardiomyopathy. Am J Cardiol 93 (2004) 1441-1443 A10
63. Porat S., Leibowitz D., Milwidsky A., et al. Transient intracardiac thrombi in amniotic fluid embolism. Br J Obstet Gynaecol 111 (2004) 506-510
64. Morgan M. Amniotic fluid embolism. Anaesthesia 34 (1979) 20-32
65. Clark S.L., Hankins G.D., Dudley D.A., et al. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol 172 (1995) 1158-1167 discussion 67-69
66. Gilbert W.M., and Danielsen B. Amniotic fluid embolism: decreased mortality in a population-based study. Obstet Gynecol 93 (1999) 973-977
67. Tuffnell D.J. United Kingdom amniotic fluid embolism register. Br J Obstet Gynaecol 112 (2005) 1625-1629
68. Steiner P.E., and Lushbaugh C.C. Landmark article, Oct. 1941: Maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics. JAMA 255 (1986) 2187-2203
69. Resnik R., Swartz W.H., Plumer M.H., et al. Amniotic fluid embolism with survival. Obstet Gynecol 47 (1976) 295-298
70. James C.F., Feinglass N.G., Menke D.M., et al. Massive amniotic fluid embolism: diagnosis aided by emergency transesophageal echocardiography. Int J Obstet Anesth 13 (2004) 279-283
71. Clark S.L. New concepts of amniotic fluid embolism: a review. Obstet Gynecol Surv 45 (1990) 360-368
72. Oi H., Kobayashi H., Hirashima Y., et al. Serological and immunohistochemical diagnosis of amniotic fluid embolism. Semin Thrombosis Hemostasis 24 (1998) 479-484
73. Benson M.D., Kobayashi H., Silver R.K., et al. Immunologic studies in presumed amniotic fluid embolism. Obstet Gynecol 97 (2001) 510-514
74. Robillard J., Gauvin F., Molinaro G., et al. The syndrome of amniotic fluid embolism: a potential contribution of bradykinin. Am J Obstet Gynecol 193 (2005) 1508-1512
75. Uszynski M., Zekanowska E., Uszynski W., et al. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism. Eur J Obstet Gynecol Reprod Biol 95 (2001) 163-166
76. McDonnell N.J., Chan B.O., and Frengley R.W. Rapid reversal of critical haemodynamic compromise with nitric oxide in a parturient with amniotic fluid embolism. Int J Obstet Anesth 16 (2007) 269-273
77. Clarke J., and Butt M. Maternal collapse. Curr Opin Obstet Gynecol 17 (2005) 157-160
78. ACOG Practice Bulletin. Induction of Labor. Clinical Management Guidelines for Obstetrician-Gynecologists. Washington D.C.: American College of Obstetricians and Gynecologists, 1999. Number 10.
79. Wagner M. From caution to certainty: hazards in the formation of evidence-based practice - a case study on evidence for an association between the use of uterine stimulant drugs and amniotic fluid embolism. Paediatr Perinat Epidemiol 19 (2005) 173-176
80. Kramer M.S., Rouleau J., Baskett T.F., et al. Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study. Lancet 368 (2006) 1444-1448
81. Pluymakers C., De Weerdt A., Jacquemyn Y., et al. Amniotic fluid embolism after surgical trauma: two case reports and review of the literature. Resuscitation 72 (2007) 324-332
82. El Kady D. Perinatal outcomes of traumatic injuries during pregnancy. Clin Obstet Gynecol 50 (2007) 582-591
83. Pearlman M.D. Motor vehicle crashes, pregnancy loss and preterm labor. Int J Gynaecol Obstet 57 (1997) 127-132
84. Green W., Robinson L.M., Rizzo A.G., et al. Pregnancy is not a sufficient indicator for trauma team activation. J Trauma Inj Infect Crit Care 63 (2007) 550-555
85. Patel S.J., Reede D.L., Katz D.S., et al. Imaging the pregnant patient for nonobstetric conditions: algorithms and radiation dose considerations. RadioGraphics 27 (2007) 1705-1722
86. Cusick S.S., and Tibbles C.D. Trauma in pregnancy. Emerg Med Clin N Am 25 (2007) 861-872
87. Barraco R., Chiu W., Clancy T., et al. Practice Management Guidelines for the Diagnosis and Management of Injury in the Pregnant Patient: The EAST Practice Management Guidelines Work Group. Available from: (2005). http://www.east.org/tpg/pregnancy.pdf Last accessed 14 January 2007
88. Muench M.V., and Canterino J.C. Trauma in pregnancy. Obstet Gynecol Clin N Am 34 (2007) 555-583
89. Gunter J.J. Intimate partner violence. Obstet Gynecol Clin N Am 34 (2007) 367-388 ix
90. Butler E.E., Colon I., Druzin M.L., et al. Postural equilibrium during pregnancy: decreased stability with an increased reliance on visual cues. Am J Obstet Gynecol 195 (2006) 1104-1108
91. Dunning K., LeMasters G., Levin L., et al. Falls in workers during pregnancy: risk factors, job hazards, and high risk occupations. Am J Ind Med 44 (2003) 664-672
92. Weiss H.B., Songer T.J., and Fabio A. Fetal deaths related to maternal injury. JAMA 286 (2001) 1863-1868
93. Cahill A.G., Bastek J.A., Stamilio D.M., et al. Minor trauma in pregnancy - is the evaluation unwarranted?. Am J Obstet Gynecol 198 (2008) 208e1-208e5
94. ACOG Educational Bulletin. Obstetric aspects of trauma management (1998), American College of Obstetricians and Gynecologists, Washington D.C. Number 251
95. Muench M.V., Baschat A.A., Reddy U.M., et al. Kleihauer-betke testing is important in all cases of maternal trauma. J Trauma-Inj Infect Crit Care 57 (2004) 1094-1098
96. Pearlman M.D., and Phillips M.E. Safety belt use during pregnancy. Obstet Gynecol 88 (1996) 1026-1029